Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Active not recruiting 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 11Neoplasm Metastasis 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Ovarian Neoplasms 2Multiple Myeloma 2Lymphoma 2Lung Neoplasms 2Hematologic Neoplasms 2Brain Neoplasms 2Uterine Neoplasms 1Urologic Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Solid Tumors 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasm, Residual 1Melanoma 1HER2-positive Breast Cancer 1HER2-Positive Primary Breast Cancer 1Glioma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Radiosurgery 23Temozolomide 9Radiotherapy 8pembrolizumab 6Cyclophosphamide 6abemaciclib 5Nivolumab 5Radiation 4Mental Status and Dementia Tests 4Bevacizumab 4trastuzumab deruxtecan 3trametinib 3pertuzumab 3osimertinib 3entrectinib 3Surveys and Questionnaires 3Proton Therapy 3Magnetic Resonance Spectroscopy 3Lomustine 3Ipilimumab 3Immunoglobulin G 3Disulfides 3Cisplatin 3tucatinib 2encorafenib 2binimetinib 2Vincristine 2Trastuzumab 2Surgical Procedures, Operative 2Spermine Synthase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Brain Neoplasms × Ado-Trastuzumab Emtansine × Clear all
NCT05593094 2026-05-26

A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors

Hoffmann-La Roche

Phase 1/2 Active not recruiting
210 enrolled
CNS

Brain Neoplasms

NCT05323955 2026-03-17

BRIDGET

Duke University

Phase 2 Active not recruiting
48 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡